Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Nov-24 4:32 PM View:  | Mirum Pharmaceuticals, Inc. (MIRM) | 08-Nov-24 | Grant | 65 | $21.05 | $1,367.99 | < 1% 335.35K to 335.42K | |
| 24-Jul-24 5:32 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 23-Jul-24 | Option Exercise | 34,013 | $2.94 | $99,862.20 | 11% 301.34K to 335.35K | |
| 20-May-24 8:14 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 20-May-24 | Disposition | 1,900 | -- | -- | (100%) 1.9K to 0 | |
| 16-May-24 4:30 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 10-May-24 | Grant | 817 | $21.05 | $17,194.60 | < 1% 300.52K to 301.34K | |
| 05-Feb-24 9:04 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 02-Feb-24 | Private Sale | 6,013 | $26.19 | $157,491.00 | (2%) 311.69K to 305.68K | |
| 09-Jan-24 8:12 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 08-Jan-24 | Private Sale | 5,209 | $28.03 | $146,033.00 | (2%) 316.9K to 311.69K | |
| 19-May-23 4:05 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 10-May-23 | Grant | 1,256 | $16.92 | $21,255.90 | < 1% 321.15K to 322.4K | (8%) |
| 02-Feb-23 5:39 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 31-Jan-23 | Grant | 50,000 | -- | -- | 18% 271.15K to 321.15K | |
| 18-Mar-24 5:37 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 09-Jan-23 | Private Sale | 5,159 | $20.62 | $106,390.00 | (2%) 305.68K to 300.52K | |
| 14-Nov-22 9:45 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 10-Nov-22 | Grant | 49 | $17.05 | $835.50 | < 1% 271.1K to 271.15K | (9%) |
| 12-May-22 9:17 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 10-May-22 | Grant | 1,500 | $13.57 | $20,349.00 | < 1% 269.6K to 271.1K | |
| 07-Jan-22 4:54 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 06-Jan-22 | Grant | 40,000 | -- | -- | 17% 229.6K to 269.6K | |
| 29-Nov-21 9:47 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 24-Nov-21 | Market Purchase | 7,000 | $14.40 | $100,800.00 | 3% 222.6K to 229.6K | (7%) |
| 01-Oct-21 8:00 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 01-Oct-21 | Market Sale | 3,672 | $19.26 | $70,708.00 | (2%) 226.27K to 222.6K | |
| 01-Oct-21 8:00 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 29-Sep-21 | Grant | 21,875 | -- | -- | 11% 204.39K to 226.27K | |
| 24-Sep-21 10:00 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 23-Sep-21 | Market Sale | 1,900 | $10.17 | $19,323.00 | 100% 0 to 1.9K | 2% |
| 12-May-21 5:41 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 10-May-21 | Grant | 1,453 | $14.62 | $21,242.90 | < 1% 202.94K to 204.39K | |
| 28-Dec-20 4:06 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 23-Dec-20 | Market Purchase | 5,000 | $18.70 | $93,480.00 | 3% 197.94K to 202.94K | (2%) |
| 12-Nov-20 5:03 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 10-Nov-20 | Grant | 1,371 | $15.27 | $20,929.70 | < 1% 196.57K to 197.94K | |
| 10-Sep-19 7:11 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 09-Sep-19 | Purchase | 4,320 | $11.14 | $48,132.00 | 2% 192.25K to 196.57K | |
| 10-Sep-19 7:11 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 06-Sep-19 | Purchase | 4,750 | $10.91 | $51,805.90 | 3% 187.5K to 192.25K |